Written Question·Department of Health and Social Care·UIN 15055
Respiratory Syncytial Virus: Vaccination
Tabled: 19 November 2024
Answered: 25 November 2024
Question
Freddie van Mierlo
Liberal Democrat — Henley and Thame
To ask the Secretary of State for Health and Social Care, when he plans to publish real world evidence on the effectiveness of the respiratory syncytial virus vaccine in the 75-80 cohort; how much such evidence has been collected; and whether such evidenc
Answer
The UK Health Security Agency is working on vaccine effectiveness analysis within the 75 to 80-year-old age group for this winter season 2024 to 2025. We are collating data on respitatory syncytial virus (RSV) hospitalisations in England and general pract...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 15055) →